Health Mechanisms of resistance to sotorasib in lung cancer identified by Alexandra Hartman Editor-in-Chief March 17, 2023 written by Alexandra Hartman Editor-in-Chief March 17, 2023 45 Oncology – First approved inhibitor once morest the KRAS oncogene. First approved inhibitor once morest the KRAS oncogene. Tumor cells rapidly adapt to the drug by increasing the number of copies of the mutated KRAS targeted by therapy. Sotorasib-resistant lung cancer cells carrying multiple copies of the mutated KRAS gene (in red). Photo: CICANCER. Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Biden asks Congress to strengthen the powers of banking regulators next post Profini.sk » The Department of Investments centrally procures cloud services for more than 30 million euros for five years You may also like Oldest Fossilized Vomit Reveals Ancient Predator’s Diet &... February 17, 2026 El Salvador: $75M Loan to Expand DoctorSV Telemedicine... February 17, 2026 Maximize Your Fitness: The Ultimate Guide to a... February 17, 2026 Computer Vision PhD Aims to Improve Disease Diagnosis... February 17, 2026 Chernobyl DNA Mutations: Effects on Workers’ Children February 17, 2026 Super Bowl Bets & Secret Signals: Inside the... February 17, 2026 Honey: Facts vs. Myths – What Science Says... February 17, 2026 Emergency Care & Family History | [Practice Name] February 17, 2026 Australia Genome Sequencing: Protecting Biodiversity & Native Species February 17, 2026 MS Research Breakthrough: Myelin Blisters & Potential for... February 17, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
